共 50 条
- [41] Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomasBMC CANCER, 2017, 17Lehtinen, BirgittaRaita, AnninaKesseli, JuhaAnnala, MattiNordfors, KristiinaYli-Harja, OlliZhang, WeiVisakorpi, TapioNykter, MattiHaapasalo, HannuGranberg, Kirsi J.
- [42] Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomasBMC Cancer, 17Birgitta LehtinenAnnina RaitaJuha KesseliMatti AnnalaKristiina NordforsOlli Yli-HarjaWei ZhangTapio VisakorpiMatti NykterHannu HaapasaloKirsi J. Granberg
- [43] GLIOMAS WITH FGFR ONCOGENIC ALTERATIONS: CLINICO-PATHOLOGICAL FEATURES, MANAGEMENT AND OUTCOMES IN PEDIATRIC, ADOLESCENT AND YOUNG ADULT PATIENTSNEURO-ONCOLOGY, 2023, 25Vanan, Magimairajan IssaiKakumanu, SaranyaPitz, MarshallHarlos, CraigKazina, ColinMcDonald, PatrickDrapeau, AnnieKaufmann, AnthonyO'Carroll, AoifeXu, QiDrimes, TinaBourne, CathyStreilein, JessicaSinha, Namita
- [44] DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMASNEURO-ONCOLOGY, 2024, 26Nobre, LianaFarouk, SameerLarsen, AlexandraBennett, JulieHo, I-ChenSiddaway, RobertMellinghoff, IngoPerreault, SebastienMagimairajan, VananLarouche, ValerieRenzi, SamueleThacker, NiravZelcer, ShaynaEllison, DavidSanti, MariaritaMacLean, NasrallahStone, SaraBale, TejusKarajannis, MatthiasTabori, UriHawkins, Cynthia
- [45] Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of FGFR1JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (05)Kobayashi, SachikoTanigawa, JunpeiKondo, HidehitoNabatame, ShinMaruoka, AzusaSho, HiroyukiTanikawa, KazukoInui, RyokoOtsuki, MichioShimomura, IichiroOzono, KeiichiHashimoto, Kunihiko
- [46] DIFFERENTIAL REGULATION OF FIBROBLAST GROWTH FACTOR-3 CONTROLS FGFR1:FGFR3 BALANCE IN CHONDROCYTES AFTER CARTILAGE INJURYOSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S137 - S137Khan, S. N.Chanalaris, A.Vincent, T. L.
- [47] Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumorsCANCER RESEARCH, 2019, 79 (13)Li, GaryKrook, MelanieRoychowdhury, SameekAvogadri, FrancescaYe, YiningMoran, Susan
- [48] Comparative analysis of FGFR1, FGFR3 and FGFR4 tyrosine kinase activities expressed as chimeric receptors in PC12 cells.FASEB JOURNAL, 1997, 11 (09): : A1057 - A1057Raffioni, SBradshaw, RA
- [49] PEDIATRIC LOW-GRADE GLIOMAS WITH FGFR1 MUTATIONS AND SPONTANEOUS HEMORRHAGE: CASE SERIESNEURO-ONCOLOGY, 2022, 24 : 95 - 95Campion, StephaniAguilar-Bonilla, Ana E.Elbabaa, SamerSmith, Amy A.
- [50] ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3BONE, 2017, 105 : 57 - 66Balek, LukasGudernova, IvaVesela, IvaHampl, MarekOralova, VeronikaKunova Bosakova, MichaelaVarecha, MiroslavNemec, PavelHall, TerenceAbbadessa, GiovanniHatch, NanBuchtova, MarcelaKrejci, Pavel